Fig. 3From: Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanomaKaplan Meier curves showing progression-free (a) and disease-specific (b) survival, calculated from the date of local therapy. PFS curves show 3 years while DSS curves show 5 years. NS = not significant; P > 0.05 by log-rank testBack to article page